Cada Dennis J, Cong Jasen, Baker Danial E
Founder and Contributing Editor, The Formulary ; Washington State University , Spokane, Washington.
Drug Information Resident, Drug Information Center, Washington State University , Spokane, Washington.
Hosp Pharm. 2014 May;49(5):466-78. doi: 10.1310/hpj4905-466.
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, call The Formulary at 800-322-4349. The May 2014 monograph topics are droxidopa, elosulfase alfa, vorapaxar, ramucirumab, and pimavanserin. The DUE/MUE is on droxidopa.
每月，《处方集专论服务》的订阅者会收到5至6篇关于新发布或处于3期临床试验后期药物的资料详实的专论。这些专论面向药学与治疗学委员会。订阅者每月还会收到关于对议程以及药学/护理在职培训有用药物的1页摘要专论。每月还会提供一份全面的目标药物利用评估/药物使用评估（DUE/MUE）。订阅后，专论将以印刷版形式发送，也可在线获取。专论可根据机构需求进行定制。现在每月会随《处方集专论服务》发布一份药物类别综述。通过《处方集》的合作，《医院药学》在本专栏发表精选综述。如需了解更多关于《处方集专论服务》的信息，请致电《处方集》800 - 322 - 4349。2014年5月的专论主题为屈昔多巴、阿加糖酶α、沃拉帕沙、雷莫西尤单抗和匹莫范色林。DUE/MUE是关于屈昔多巴的。
